FAsenra Safety Trial in India

Clinical trial NCT05384938 · COMPLETED

Trial details

NCT number: NCT05384938
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India

Start date: 2021-11-19
Primary completion: 2023-07-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.